A new analysis suggests infrequent screening has resulted in an increase in the number of men diagnosed with the metastatic form of the disease.
For decades, experts have said the diagnostic used to screen patients for prostate cancer is too unreliable to use routinely because it produces high rates of false positives and often results in additional unnecessary and invasive tests, as well as overtreatment. However, a new study suggests efforts to limit the use of the prostate-specific antigen (PSA) test may be partially responsible for a rise in incidences of the most aggressive form of the disease.
Source: newsweek
No comments:
Post a Comment